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Background and Purpose: The pathogenesis of spontaneous cervical artery dissections
(sCAD) and its best medical treatment are debated. This may be due to a lack of clear
classification of sCAD. We propose the new Borgess classification of sCAD, based on the
presence or absence of intimal tear as depicted on imaging studies and effect on blood
flow.
Materials and Methods:This is a single-center investigator-initiated registry on consecu-
tive patients treated for sCAD. In the Borgess classification, type I dissections have intact
intima and type II dissections have an intimal tear.
Results: Forty-four patients and 52 dissected arteries were found. Forty-nine of 52 dis-
sections (93%) were treated with dual anti-platelet therapy. Twenty-one of 52 dissections
were type I; 31 were type II. Type I dissections were more likely to present with ischemic
symptoms [stroke, transient ischemic attack (TIA)] (p=0.001). More type I dissections
occurred in the vertebral artery, while more type II dissections occurred in the internal
carotid artery (p<0.001). Follow-up averaged 18.1 months (range: 3–108 months) with
no recurrent ischemic events (stroke, TIA), deaths, or hemorrhage. Forty-six vessels had
6 month follow-up on medical treatment; 19/46 (41%) healed.Type I dissections were more
likely to heal than type II (p<0.001).
Conclusion: The two dissection types in the Borgess classification appear to relate to
clinical presentation and rate of healing, making the classification useful in clinical man-
agement. Dual anti-platelet therapy for sCAD seems to have a very low risk of subsequent
stroke; however, a large prospective study is needed to investigate the best treatment.
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INTRODUCTION
Despite the fact that spontaneous cervical artery dissection
(sCAD) is relatively common and easily diagnosed using mod-
ern imaging techniques, its pathophysiology is still surprisingly
poorly understood and its treatment still debated (1–6). Two
common explanations describe its pathogenesis: inside-out and
outside-in theories. The traditional inside-out theory suggests
that a tear in the intima is the primary insult allowing for
blood to enter the vascular wall. The newer outside-in the-
ory proposes that an intramural hematoma forms first with or
without subsequent intimal tear. The proposed treatment strate-
gies for sCAD are even more complex. The ongoing Cervical
Artery Dissection In Stroke Study (CADISS) has six different
treatment groups (aspirin, dipyridamole, clopidogrel, dual anti-
platelet, unfractionated heparin bridged to warfarin, and low-
molecular-weight heparin bridged to warfarin) (6). Furthermore,
a few authors have begun to advocate endovascular approaches as
a first-line of treatment (7–10). We believe this confusion con-
cerning sCAD pathophysiology and treatment is due, at least
in part, to the poor definition and classification of the disease
process.
The Borgess classification presented here is based on review of
imaging findings of the Borgess Medical Center Spontaneous Cer-
vical Arterial Dissection Registry (BMC-sCAD) at presentation,
throughout the patients’ clinical course, and evolution on follow-
up. We hope that this new classification will allow for easier and
more precise descriptions of sCAD that may impact treatment rec-
ommendations and improve prediction of long-term prognosis.
BORGESS CLASSIFICATION OF sCAD
The defining feature of the Borgess classification of sCAD is the
presence or absence of an intact tunica intima in the dissected
vessel and its impact on blood flow, as assessed using available
imaging techniques. Intimal tear was considered present if the
imaging study demonstrated contrast pooling outside the vascu-
lar lumen (side-wall aneurysm), false lumen with intimal flap, or
if there was a fusiform dilatation of the vessel. The impact on the
cerebral flow was assessed by the persistence (yes or no) of blood
flow reaching the intra-cranial circulation.
Type I dissections have an intact intima while type II dissec-
tions have a disruption of the intima; both type I and type II are
divided into two subtypes (Figures 1 and 2). Type IA dissections
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FIGURE 1 |Type IA and type IB dissections. Type I dissections show an
intact intima. Type IA (left) has persistent antegrade flow. Type IB (right) is
completely occluded.
FIGURE 2 |Type IIA and type IIB dissections. Type II dissections show
intimal disruption. Type IIA (left) has a small disruption of the intima with a
small side-wall aneurysm. Type IIB (right) shows a clear intimal flap and
aneurysmal dilation.
show varying degrees of luminal stenosis due to an intramural
hematoma, but antegrade flow persists. Type IB dissections have
total occlusion of the lumen due to the intramural hematoma
with absence of antegrade flow. Type IIA dissections have a small
focal disruption of the intima with development of a side-walled
aneurysm (the tunica adventitia is intact so the term pseudoa-
neurysm is inaccurate) of varying size and flow stagnation within
the aneurysm. Type IIB dissections have a large disruption of the
intima, with either false lumen (intimal flap can be seen and the
false lumen may or may not reconnect with the original lumen)
or aneurysmal dilation of the affected vessel.
MATERIALS AND METHODS
STUDY DESIGN AND SUBJECT ELIGIBILITY
Borgess Medical Center is a high-volume acute ischemic stroke
center, treating approximately 300 stroke and 300 transient
ischemic attack (TIA) cases per year. The BMC-sCAD is a non-
randomized, single-center, single-operator, investigator-initiated
registry of all consecutive patients presenting to our service with
sCAD between January 2002 and December 2010. All patients
gave written informed consent for the procedures. The proto-
col for this registry was approved by the Institutional Review
Board, including approval to waive informed consent for the data
collection and analysis. Data were entered prospectively and ret-
rospectively in a secure database (MD Analyze; Medtech Global,
South Melbourne, VIC, Australia; www.medtechglobal.com) and
then analyzed retrospectively.
Patients suffering from iatrogenic dissections and patients with
acute ischemic stroke (within 6 h of ictus) who were treated with
the acute ischemic stroke protocol (intra-arterial or intra-venous)
were excluded. Diagnosis of sCAD was based on clinical signs
of local symptoms (as defined below) or cerebral ischemia and
confirmed by at least one imaging study including magnetic res-
onance angiography (MRA), computed tomography angiography
(CTA), or diagnostic cerebral angiography (DCA). Both internal
carotid artery (ICA) dissections and vertebral artery (VA) dis-
sections were included. Dissection was classified as spontaneous
when occurring unexpectedly or secondary to a usual event such as
abrupt neck movement, minor neck or head trauma, chiropractic
manipulation, or coughing.
Per protocol, patients were started on dual anti-platelet ther-
apy consisting of clopidogrel (75 mg daily) after a loading dose of
300 mg and aspirin (81 mg daily) immediately after imaging con-
firmation of dissection. The presence of a cortical infarct did not
preclude the initiation of dual anti-platelet therapy. Endovascular
treatment was not performed as first-line treatment, except in a
few early cases due to confusion about the best treatment modal-
ity to decrease the patient’s risk of subsequent stroke. All patients
were instructed to contact the neurointerventional service if they
experienced any symptoms suggestive of new or recurrent local
symptoms or cerebral ischemia. All patients were required to have
imaging and clinical follow-up at a minimum of 3 month inter-
vals until resolution or interval progression of the dissection was
documented by MRA, CTA, or DCA. Endovascular treatment was
offered if follow-up visits documented persistence of local symp-
toms or the enlargement/persistence of a previously documented
large aneurysm.
DATA COLLECTION
Demographics (age, gender, and race), the clinical presentation
upon admission, and the location of the dissections were col-
lected prospectively. Clinical presentation was divided into three
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categories: stroke, TIA, and local signs/symptoms. Stroke was iden-
tified by clinical symptoms and confirmed by either MRI or CT
scans, defined as diffusion-weighted image abnormality on MRI
or hypodensity on CT. TIA was defined as a temporary episode of
neurologic dysfunction without evidence of infarction on imag-
ing. Local signs and symptoms included neck pain, headache,
Horner’s syndrome, and tinnitus. If patients had ischemic and
local symptoms, they were classified under ischemic symptoms.
Retrospectively collected data included the type of dissection
(type IA, IB, IIA, or IIB) this was obtained from reviewing the
imaging studies. Intimal tear was considered present (Borgess Type
II) if signs of contrast material were present outside the lumen on
DCA or CTA (or flow related signal on the MRA). Sixteen ves-
sels had only MRA available 31% (16/52). Other data collected
retrospectively included the presence or absence of vessel kink-
ing, and fibromuscular dysplasia (FMD). Reconstitution of the
vessel lumen to its expected size, with resolution of the side-wall
aneurysm (if present), was considered complete healing. Side-wall
aneurysm was considered small if its longest diameter was equal
to or smaller than the diameter of the parent vessel.
STATISTICAL ANALYSIS
Equality of proportions was tested using a 2-Proportion z-test. If
a low number of successes existed in the data, Fisher’s Exact test
was used instead. The predictive value of the variables for type I or
type II was examined using binary logistic regression. All hypoth-
esis tests were conducted at the 0.05 significance level using the
Minitab 16 statistical software.
RESULTS
From January 2002 through December 2010, 44 patients and 52
dissected arteries were found. Diagnosis was established in all
patients by at least one imaging study. Data stratified by dissected
vessel is summarized in Table 1.
Twenty-one patients (48%) presented with ischemic signs and
symptoms (stroke or TIA), 20 patients (45%) presented with local
symptoms only, and 3 patients presented with non-specific signs
(dizziness in patients with ICA dissection). Seven patients (16%)
had multiple dissected vessels with a total of 15 vessels; 7 of the
vessels were considered the source of the patients’ symptoms (at
the same side of the neck pain, Horner’s syndrome, or the stroke on
imaging studies) while the other 8 were considered asymptomatic.
Of the 44 patients, 41 (93%) were treated with aspirin and clopi-
dogrel and 1 with aspirin only (patient preference), 1 declined
medical treatment, and 1 was not medically treated due to ele-
vated INR caused by advanced liver cirrhosis. Clinical and imag-
ing follow-up was available for 42 patients (50 vessels). Follow-
up averaged 18.1 months (range: 3–108 months). There were
no recurrent ischemic events (stroke or TIA), deaths, sympto-
matic intra-cranial hemorrhage, or major extracranial hemor-
rhage reported during follow-up. The most common complaint
during follow-up was headache in 5 (12%) and neck pain in 2
(5%) of the 43 patients.
Of the 52 vessels, 10 were treated by endovascular techniques (4
stents were placed to reconstitute the vascular lumen, 4 side-wall
aneurysms were coiled, and 2 vessels were sacrificed), 5 of which
were treated within 6 months of presentation. One vessel was lost
Table 1 | Characteristics of carotid and vertebral artery dissections.
Carotid artery
dissection n=38 (%)
Vertebral artery
dissection n=14 (%)
DEMOGRAPHICS
Women 19 (50) 8 (57)
Men 19 (50) 6 (43)
AGE
Mean 52.3 44.8
VESSEL DISSECTED
Left 25 (66) 8 (57)
Right 13 (34) 6 (43)
CLINICAL PRESENTATION (PERVESSEL)
Ischemia 13 (34) 8 (57)
Local 14 (37) 6 (43)
Asymptomatic 8 (21) 0 (0)
Non-specific 3 (8) 0 (0)
DIAGNOSTIC METHOD
MRA 30 (52) 10 (43)
CTA 6 (10) 3 (14)
DSA 22 (38) 10 (43)
INITIAL IMAGING FEATURES PRESENT
Fibromuscular dysplasia 15 (39) 3 (21)
Vessel kinking 15 (39) 7 (50)
Type I dissection 10 (26) 11 (79)
Type II dissection 28 (74) 3 (21)
to follow-up, leaving 46 vessels on medical treatment alone with
at least 6 months of imaging follow-up. Healing, as defined here,
occurred in 19/46 vessels (41%), no healing occurred in 27/46
vessels (59%), and one type I dissection progressed to a type II
dissection (this was considered no healing). Four type II dissec-
tions healed, with an average time to healing of 4.8 months (range:
3–8 months) and all were small side-wall aneurysms. Overall, of
the 15 small side-wall aneurysms present, 5 healed on medical
therapy alone (33%). Fifteen type I dissections healed completely,
with an average time to healing of 4.2 months (range: 3 weeks to
11 months). Data stratified by type I and type II is presented in
Table 2.
Vertebral artery dissections were predominately type I (11/14,
79%), while ICA dissections were predominately type II (28/38,
74%) (p< 0.001). Type I dissections had statistically higher
chances to present with ischemic symptoms (14/21, 67%) when
compared to type II dissections (7/31, 22.5%) (p= 0.001), while
Type II dissections had higher chances to present with local symp-
toms (15/31, 48%) than type I dissections (5/21, 24%), almost
reaching a statistical significance (p= 0.057). Type I, however, had
a statistically higher chance of healing than type II (75 vs. 15%,
respectively) (p< 0.001).
DISCUSSION
Spontaneous cervical artery dissection is an important cause of
stroke in younger patients accounting for as much as 20% of
ischemic stroke in younger patients (11–16). Yet despite its preva-
lence, its pathogenesis, risk of subsequent ischemic stroke, and best
treatment are still debated.
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Table 2 |Type I and type II dissections.
Type I, n=21 (%) Type IA, n=15 (%) Type IB, n=6 (%) Type II, n=31 (%) Type IIA, n=24 (%) Type IIB, n=7 (%)
CLINICAL PRESENTATION
Ischemic symptoms 14 (67) 11 (73) 3 (50) 7 (23) 5 (21) 2 (29)
Local symptoms 5 (24) 2 (13) 3 (50) 15 (48) 15 (63) 0 (0)
Asymptomatic 1 (5) 1 (7) 0 (0) 7 (23) 3 (12) 4 (57)
Non-specific symptoms 1 (5) 1 (7) 0 (0) 2 (6) 1 (4) 1 (14)
IMAGING EVOLUTIONAT 6MONTHS
Healed 15/20 (75) 12/14 (87)a 3/5 (60)b 4/26 (15) 4/21 (19)c 0/5 (0)d
No change 4/20 (20) 2/14 (13)a 2/5 (40)b 22/26 (85) 17/21 (81)c 5/5 (100)d
aOne type IA vessel progressed to type II.
bOne type IB vessel was treated with endovascular techniques within the first 6 months.
cThree type IIA vessels were treated with endovascular techniques within the first 6 months.
dOne type IIB vessel was treated with endovascular techniques within the first 6 months and one was lost to follow-up.
Until recently, dissection was believed to be due to a tear in the
intima (inside-out theory) (14). However, new evidence suggests
that the pathological process may begin with degenerative changes
at the medial-adventitial border associated with neoangiogenesis
of capillary vessels branching from the vasa vasorum in the adven-
titia (outside-in theory) (17, 18). In the BMC-sCAD registry, clear
imaging signs of intimal tear were found in only 60% of cases,
as seen by contrast extravasation into the vascular wall (Borgess
classification type II). Clear intimal flap was found in only 13%
of our cases (type IIB). Other authors have reported similarly low
percentages of intimal flap on CTA at 25% (19). This observation
supports the outside-in theory of arterial dissection, since if the
intimal tear is the initial insult, we would expect to encounter inti-
mal tears at a much higher rate. It is conceivable that there could
be an initial intimal tear that healed by the time of imaging or
went undetected if its extremely small size did not allow for detec-
tion of extra-luminal contrast pooling. However, if the original
intimal tear is extremely small, there is still not an explanation for
how such a large amount of blood enters the arterial wall causing
symptomatic dissection and how it is closed so quickly afterward.
In our series, when an intimal tear was present (type II) it rarely
resolved (only about 15% of cases). In the few cases in which the
intimal tear did resolve, it took approximately 5 months. There-
fore, a more logical explanation is that in the cases where no intimal
tear is found, there was never one to begin with. Other authors
also commented on the rarity of finding evidence of intimal
tear/flap (18–20). These arguments point to an initial abnormality
at the vascular wall level (outside-in theory) as the most plausible
explanation.
Additionally, in our registry most ICA dissections were type II
(74%) while the majority of VA dissections were type I (79%),
a finding that is difficult to reconcile with the outside-in theory
as proposed. If in both cases the dissection starts inside the vas-
cular wall, why is there a higher incidence of intimal tear in the
ICA compared to the VA? We believe that this difference may be
related to the higher mobility of the ICA in comparison to the
VA, which is encased in the cervical vertebrae. This observation
argues for a mechanical component (e.g., trauma, sudden twist-
ing) leading to intimal tear, suggesting tears are probably not only
due to the extension of the intramural hematoma rupturing the
intimal layer as the pure outside-in theory states. A mechanical
component could play a role at least in certain circumstances. A
modified theory for the genesis of cervical arterial dissection is that
the process begins as an outside-in process with formation of an
intramural hematoma (type I dissection) which may or may not
become symptomatic depending on the degree of vascular steno-
sis, clot formation, and collateral blood supply. In certain cases,
a superimposed minor trauma may occur and intimal tear may
develop in this already-dissected vessel; one case of such a conver-
sion from type I to type II occurred in our registry, which further
strengthens our belief in this possibility.
The risk of subsequent stroke following sCAD while the patient
is on medical therapy (anticoagulant or anti-platelet) has been
very low (1–2%) in multiple retrospective series (21–27). This
estimation was recently challenged by a prospective study report-
ing the overall subsequent stroke risk following dissection at 10.4%
(12.4% for aspirin, 8.3% for warfarin) (28). Our registry compares
favorably with its subsequent stroke rate of 0%, which may be due
to the protective effect of the dual anti-platelet therapy and its
rapid initiation (as soon as the diagnosis was confirmed). The two
types of dissections we describe may have different risks of subse-
quent stroke. A larger prospective study documenting the real risk
of subsequent stroke in these patients and comparing the protec-
tive effect of dual anti-platelet vs. ASA or warfarin is certainly long
overdue.
Perhaps the most practical impact for this new classification
of sCAD is its ability to predict healing following medical ther-
apy alone. Because we performed direct vascular imaging, we
were able to define healing as the reconstitution of the vessel
lumen to normal anatomy as opposed to defining healing as the
persistence or recurrence of antegrade flow as is often reported
(12, 21, 29). Reconstitution of antegrade flow was observed in
45/46 (98%) dissections on follow-up. However, when looking at
true healing, as opposed to mere antegrade flow, a substantially
higher percentage of type I dissections healed compared to type
II (75 vs. 15%, p< 0.001). Type IA dissections had a better rate
of healing (80%) compared to type IB (60%). Type IIA dissec-
tions healed only 19% of the time, while no type IIB healed (0%).
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When comparing the size of the type IIA side-walled aneurysms,
5/15 vessels with a small aneurysm healed (33%), while no large
aneurysms healed (0/10). This data suggests that type I dissections
undergo substantial remodeling/healing while type II dissections
do not. This different healing rate may in part be dependent on
the presence of an intimal tear, the extent of the tear, and the
preservation of antegrade flow. In agreement with other studies,
we found that if healing does occur, it will occur within the first
6 months (29).
This paper has limitations. The absence of an independent
observer to assess the recurrent stroke rate is one limitation, as
is the study’s sample size. The more significant limitation is that
the classification is based on the presence or absence of intimal
tear as depicted by current available imaging technologies, which
are low resolution for examining the intima. However, this limi-
tation is unavoidable given that there are no other ways to make
this distinction short of autopsy, which would obviously limit the
classification’s use in treatment and prognosis. Therefore, despite
these limitations this classification could be useful.
After analyzing this registry, we have adjusted our clinical prac-
tice. Dual anti-platelet therapy is the first-line of treatment with
clinical and imaging follow-up at 6 months. The risk of subse-
quent stroke and further remodeling of the vascular wall are both
extremely low. We reserve endovascular techniques for specific
cases, such as to stent a dissected vessel when the CBF has decreased
beyond the compensatory capability of the collateral blood supply.
The endovascular approach could also be useful for treating large
side-walled aneurysms with persistent local symptoms. The exact
place for endovascular treatment is still not clear; however, using
this classification, a more rational recommendation could be put
forward beyond the “indicated or not indicated” dichotomy.
CONCLUSION
We believe that the Borgess classification of sCAD helps to plan
treatment and predict healing following medical treatment. The
registry supports a modified outside-in theory of pathogenesis
of sCAD. Dissections without intimal tear (type I) had a higher
rate of healing than dissections with intimal tear (type II). Dual
anti-platelet therapy appears to be beneficial in reducing the risk of
subsequent stroke. A large, prospective, randomized trial is needed
to define the best medical treatment for sCAD.
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